LLY · News · 20261102N

Market Demand - GLP-1

ELI LILLY & Co · 2026-11-02 · Importance 63 · Surprise 64

A report on Lilly’s October 29 results said worldwide volume for its medicines rose 53%, while realized prices fell 15%. The combination points to strong demand alongside substantial pricing pressure. It specifically frames the balance between expanding demand and lower realized prices as a key issue for Lilly’s Mounjaro and Zepbound franchise.